{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:32:28Z","timestamp":1790908348079,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006108","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000}}],"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["02PK2178"],"award-info":[{"award-number":["02PK2178"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006108","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T13:52:05Z","timestamp":1512654725000},"page":"e0006108","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":110,"title":["A thermostable messenger RNA based vaccine against rabies"],"prefix":"10.1371","volume":"11","author":[{"given":"Lothar","family":"Stitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Schnee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Mutzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ketterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kramps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-0683","authenticated-orcid":true,"given":"Benjamin","family":"Petsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1016\/j.vaccine.2011.05.070","article-title":"Vaccine stabilization: research, commercialization, and potential impact","volume":"29","author":"D Kristensen","year":"2011","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1016\/j.vaccine.2007.02.052","article-title":"Freezing temperatures in the vaccine cold chain: a systematic literature review","volume":"25","author":"DM Matthias","year":"2007","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.vaccine.2006.08.028","article-title":"A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries","volume":"25","author":"T Wirkas","year":"2007","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4161\/hv.5.1.6494","article-title":"Characterization of the freeze sensitivity of a hepatitis B vaccine","volume":"5","author":"D Chen","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"D Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/17425247.2014.901308","article-title":"Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines","volume":"11","author":"RP Deering","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e0004746","DOI":"10.1371\/journal.pntd.0004746","article-title":"An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs","volume":"10","author":"M Schnee","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"B Petsch","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2144\/000112593","article-title":"Long-term storage of DNA-free RNA for use in vaccine studies","volume":"43","author":"KL Jones","year":"2007","journal-title":"Biotechniques"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"M Fotin-Mleczek","year":"2011","journal-title":"J Immunother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#","article-title":"In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies","volume":"30","author":"I Hoerr","year":"2000","journal-title":"Eur J Immunol"},{"key":"ref12","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","author":"M Alberer","year":"2017","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-540-72167-3_11","article-title":"Vaccination with messenger RNA (mRNA)","author":"S Pascolo","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"F Cliquet","year":"1998","journal-title":"Journal of Immunological Methods"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetmic.2008.10.030","article-title":"Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein","volume":"136","author":"S Saxena","year":"2009","journal-title":"Vet Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4161\/hv.1.5.2110","article-title":"Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis","volume":"1","author":"MK Sudarshan","year":"2005","journal-title":"Hum Vaccin"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1016\/j.vaccine.2016.10.015","article-title":"Thermotolerance of an inactivated rabies vaccine for dogs","volume":"34","author":"FJ Lankester","year":"2016","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.vaccine.2015.03.025","article-title":"Rabies vaccine preserved by vaporization is thermostable and immunogenic","volume":"33","author":"TG Smith","year":"2015","journal-title":"Vaccine"},{"key":"ref19","unstructured":"Montagnon B, Fanget B (1996) Purified Vero cell vaccine for humans, WHO Laboratory techniques in rabies 4th edition, chapter 26. 4."}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006108","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:57:53Z","timestamp":1540245473000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006108"}},"subtitle":[],"editor":[{"given":"Charles E.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":19,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006108","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0006108","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}